A detailed history of Lpl Financial LLC transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 35,173 shares of MRVI stock, worth $193,451. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,173
Previous 26,414 33.16%
Holding current value
$193,451
Previous $189,000 54.5%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$6.84 - $9.73 $59,911 - $85,225
8,759 Added 33.16%
35,173 $292,000
Q2 2024

Aug 07, 2024

BUY
$6.87 - $11.34 $31,911 - $52,674
4,645 Added 21.34%
26,414 $189,000
Q1 2024

May 10, 2024

BUY
$5.11 - $8.76 $3,030 - $5,194
593 Added 2.8%
21,769 $188,000
Q4 2023

Feb 14, 2024

SELL
$4.7 - $9.87 $5,268 - $11,064
-1,121 Reduced 5.03%
21,176 $138,000
Q3 2023

Nov 13, 2023

BUY
$9.14 - $12.85 $10,465 - $14,713
1,145 Added 5.41%
22,297 $222,000
Q2 2023

Jul 31, 2023

BUY
$12.09 - $15.0 $3,989 - $4,950
330 Added 1.58%
21,152 $262,000
Q1 2023

May 10, 2023

BUY
$12.99 - $16.48 $102,608 - $130,175
7,899 Added 61.12%
20,822 $291,000
Q4 2022

Feb 07, 2023

BUY
$12.5 - $24.78 $31,800 - $63,040
2,544 Added 24.51%
12,923 $184,000
Q3 2022

Nov 14, 2022

BUY
$20.6 - $30.37 $213,807 - $315,210
10,379 New
10,379 $265,000
Q1 2022

May 16, 2022

SELL
$24.46 - $40.92 $144,044 - $240,977
-5,889 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$35.0 - $45.94 $5,250 - $6,891
-150 Reduced 2.48%
5,889 $247,000
Q3 2021

Nov 15, 2021

SELL
$36.8 - $60.62 $33,892 - $55,831
-921 Reduced 13.23%
6,039 $296,000
Q2 2021

Aug 13, 2021

BUY
$32.46 - $45.0 $225,921 - $313,200
6,960 New
6,960 $290,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $723M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.